{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:25:46Z","timestamp":1787016346135,"version":"build-2736575974"},"reference-count":46,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"9","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1037304"],"award-info":[{"award-number":["APP1037304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1083548"],"award-info":[{"award-number":["APP1083548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,9,6]]},"abstract":"<jats:p>Antibodies to the M protein and SpeC resolve streptococcal toxic shock syndrome in HLA-humanized mice.<\/jats:p>","DOI":"10.1126\/sciadv.aax3013","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:14:15Z","timestamp":1567624455000},"source":"Crossref","is-referenced-by-count":21,"title":["Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-699X","authenticated-orcid":true,"given":"Manisha","family":"Pandey","sequence":"first","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainslie","family":"Calcutt","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ozberk","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-683X","authenticated-orcid":true,"given":"Zhenjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-7952","authenticated-orcid":true,"given":"Matthew","family":"Croxen","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta and ProvLab, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5120-7675","authenticated-orcid":true,"given":"Jessica","family":"Powell","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Langshaw","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-4579","authenticated-orcid":true,"given":"Jamie-Lee","family":"Mills","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda E.-C.","family":"Jen","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-815X","authenticated-orcid":true,"given":"James","family":"McCluskey","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Robson","sequence":"additional","affiliation":[{"name":"Sullivan and Nicolaides Pathology, Brisbane, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta and ProvLab, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-248X","authenticated-orcid":true,"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[{"name":"Institute for Glycomics, Griffith University, Gold Coast, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/11634180-000000000-00000"},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention ABCs report: Group A Streptococcus 2016; www.cdc.gov\/abcs\/reports-findings\/survreports\/gas16.html."},{"key":"e_1_3_2_4_2","unstructured":"Group A streptococcal diseases: For health professionals; www.canada.ca\/en\/public-health\/services\/diseases\/group-a-streptococcal-diseases\/health-professionals.html#a5."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"ofy177","DOI":"10.1093\/ofid\/ofy177","article-title":"Increasing rates of invasive group a streptococcal disease in Alberta, Canada; 2003\u20132017","volume":"5","author":"Tyrrell G. J.","year":"2018","unstructured":"G. J. Tyrrell, S. Fathima, J. Kakulphimp, C. Bell, Increasing rates of invasive group a streptococcal disease in Alberta, Canada; 2003\u20132017. Open Forum Infect. Dis. 5, ofy177 (2018).","journal-title":"Open Forum Infect. Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1402.070888","article-title":"Severe Streptococcus pyogenes infections, United Kingdom, 2003\u20132004","volume":"14","author":"Lamagni T. L.","year":"2008","unstructured":"T. L. Lamagni, S. Neal, C. Keshishian, N. Alhaddad, R. George, G. Duckworth, J. Vuopio-Varkila, A. Efstratiou, Severe Streptococcus pyogenes infections, United Kingdom, 2003\u20132004. Emerg. Infect. Dis. 14, 202\u2013209 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_7_2","unstructured":"A. Efstratiou T. Lamagni Epidemiology of Streptococcus pyogenes in Streptococcus Pyogenes: Basic Biology to Clinical Manifestations J. J. Ferretti D. L. Stevens V. A. Fischetti Eds. (University of Oklahoma Health Sciences Center 2016)."},{"key":"e_1_3_2_8_2","unstructured":"T. Proft J. D. Fraser Streptococcal superantigens: Biological properties and potential role in disease in Streptococcus pyogenes: Basic Biology to Clinical Manifestations J. J. Ferretti D. L. Stevens V. A. Fischetti Eds. (University of Oklahoma Health Sciences Center 2016)."},{"key":"e_1_3_2_9_2","first-page":"358","article-title":"Identification of two new core chromosome-encoded superantigens in Streptococcus pyogenes; speQ and speR","volume":"78","author":"Reglinski M.","year":"2019","unstructured":"M. Reglinski, S. Sriskandan, C. E. Turner, Identification of two new core chromosome-encoded superantigens in Streptococcus pyogenes; speQ and speR. J. Inf. Secur. 78, 358\u2013363 (2019).","journal-title":"J. Inf. Secur."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","article-title":"Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden","volume":"45","author":"Darenberg J.","year":"2007","unstructured":"J. Darenberg, B. Luca-Harari, A. Jasir, A. Sandgren, H. Pettersson, C. Schalen, M. Norgren, V. Romanus, A. Norrby-Teglund, B. H. Normark, Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45, 450\u2013458 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.165.4.2306","article-title":"Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome","volume":"165","author":"McCormick J. K.","year":"2000","unstructured":"J. K. McCormick, T. J. Tripp, S. B. Olmsted, Y. V. Matsuka, P. J. Gahr, D. H. Ohlendorf, P. M. Schlievert, Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. J. Immunol. 165, 2306\u20132312 (2000).","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/iai.61.4.1194-1201.1993","article-title":"Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5","volume":"61","author":"Kotb M.","year":"1993","unstructured":"M. Kotb, H. Ohnishi, G. Majumdar, S. Hackett, A. Bryant, G. Higgins, D. Stevens, Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect. Immun. 61, 1194\u20131201 (1993).","journal-title":"Infect. Immun."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.151.3.1419","article-title":"Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein","volume":"151","author":"Wang B.","year":"1993","unstructured":"B. Wang, P. M. Schlievert, A. O. Gaber, M. Kotb, Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J. Immunol. 151, 1419\u20131429 (1993).","journal-title":"J. Immunol."},{"key":"e_1_3_2_14_2","first-page":"404","article-title":"Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation","volume":"10","author":"Pahlman L. I.","year":"2008","unstructured":"L. I. Pahlman, A. I. Olin, J. Darenberg, M. M\u00f6rgelin, M. Kotb, H. Herwald, A. Norrby-Teglund, Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell. Microbiol. 10, 404\u2013414 (2008).","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff M. R.","year":"2003","unstructured":"M. R. Batzloff, W. A. Hayman, M. R. Davies, M. Zeng, S. Pruksakorn, E. R. Brandt, M. F. Good, Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8- and diphtheria toxoid-specific antibodies to protection. J. Infect. Dis. 187, 1598\u20131608 (2003).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500157"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1501994","article-title":"Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci","volume":"196","author":"Pandey M.","year":"2016","unstructured":"M. Pandey, R. Mortensen, A. Calcutt, J. Powell, M. R. Batzloff, J. Dietrich, M. F. Good, Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci. J. Immunol. 196, 3364\u20133374 (2016).","journal-title":"J. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41541-018-0053-9","article-title":"Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy","volume":"3","author":"Pandey M.","year":"2018","unstructured":"M. Pandey, V. Ozberk, E. L. Langshaw, A. Calcutt, J. Powell, M. R. Batzloff, T. Rivera-Hernandez, M. F. Good, Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy. NPJ Vaccines 3, 15 (2018).","journal-title":"NPJ Vaccines"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"39274","DOI":"10.1038\/srep39274","article-title":"Novel platform technology for modular mucosal vaccine that protects against streptococcus","volume":"6","author":"Zaman M.","year":"2016","unstructured":"M. Zaman, V. Ozberk, E. L. Langshaw, V. McPhun, J. L. Powell, Z. N. Phillips, M. F. Ho, A. Calcutt, M. R. Batzloff, I. Toth, G. R. Hill, M. Pandey, M. F. Good, Novel platform technology for modular mucosal vaccine that protects against streptococcus. Sci. Rep. 6, 39274 (2016).","journal-title":"Sci. Rep."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4161\/hv.23224","article-title":"Immunogenicity in mice and non-human primates of the group A streptococcal J8 peptide vaccine candidate conjugated to CRM197","volume":"9","author":"Caro-Aguilar I.","year":"2014","unstructured":"I. Caro-Aguilar, E. Ottinger, R. W. Hepler, D. D. Nahas, C. Wu, M. F. Good, M. Batzloff, J. G. Joyce, J. H. Heinrichs, J. M. Skinner, Immunogenicity in mice and non-human primates of the group A streptococcal J8 peptide vaccine candidate conjugated to CRM197. Hum. Vaccin. Immunother. 9, 488\u2013496 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"e0198658","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski S.","year":"2018","unstructured":"S. Sekuloski, M. R. Batzloff, P. Griffin, W. Parsonage, S. Elliott, J. Hartas, P. O\u2019Rourke, L. Marquart, M. Pandey, F. A. Rubin, J. Carapetis, J. McCarthy, M. F. Good, Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLOS ONE 13, e0198658 (2018).","journal-title":"PLOS ONE"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-94-007-0940-9_12","article-title":"The nonideal coiled coil of M protein and its multifarious functions in pathogenesis","volume":"715","author":"Ghosh P.","year":"2011","unstructured":"P. Ghosh, The nonideal coiled coil of M protein and its multifarious functions in pathogenesis. Adv. Exp. Med. Biol. 715, 197\u2013211 (2011).","journal-title":"Adv. Exp. Med. Biol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.resmic.2004.12.009","article-title":"M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats","volume":"156","author":"Vohra H.","year":"2005","unstructured":"H. Vohra, N. Dey, S. Gupta, A. K. Sharma, R. Kumar, D. McMillan, M. F. Good, M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats. Res. Microbiol. 156, 575\u2013582 (2005).","journal-title":"Res. Microbiol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JCM.00312-09","article-title":"emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: Implications for vaccine development","volume":"47","author":"Steer A. C.","year":"2009","unstructured":"A. C. Steer, G. Magor, A. W. J. Jenney, J. Kado, M. F. Good, D. McMillan, M. Batzloff, J. R. Carapetis, emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: Implications for vaccine development. J. Clin. Microbiol. 47, 2502\u20132509 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1700858114"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: An update","volume":"55","author":"McCormick J. K.","year":"2001","unstructured":"J. K. McCormick, J. M. Yarwood, P. M. Schlievert, Toxic shock syndrome and bacterial superantigens: An update. Annu. Rev. Microbiol. 55, 77\u2013104 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004155"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg J.","year":"2003","unstructured":"J. Darenberg, N. Ihendyane, J. Sj\u00f6lin, E. Aufwerber, S. Haidl, P. Follin, J. Andersson, A. Norrby-Teglund; The Streptlg Study Group, Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37, 333\u2013340 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau3776"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1128\/IAI.68.9.5011-5017.2000","article-title":"Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome","volume":"68","author":"Roggiani M.","year":"2000","unstructured":"M. Roggiani, J. A. Stoehr, S. B. Olmsted, Y. V. Matsuka, S. Pillai, D. H. Ohlendorf, P. M. Schlievert, Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect. Immun. 68, 5011\u20135017 (2000).","journal-title":"Infect. Immun."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.178.5.3076","article-title":"HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis","volume":"178","author":"Nooh M. M.","year":"2007","unstructured":"M. M. Nooh, N. El-Gengehi, R. Kansal, C. S. David, M. Kotb, HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178, 3076\u20133083 (2007).","journal-title":"J. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1586\/14760584.2015.1081817","article-title":"Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci","volume":"14","author":"Good M. F.","year":"2015","unstructured":"M. F. Good, M. Pandey, M. R. Batzloff, G. J. Tyrrell, Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci. Expert Rev. Vaccines 14, 1459\u20131470 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-233"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4049\/jimmunol.177.2.1221","article-title":"Streptococcal M protein: A multipotent and powerful inducer of inflammation","volume":"177","author":"P\u00e5hlman L. I.","year":"2006","unstructured":"L. I. P\u00e5hlman, M. M\u00f6rgelin, J. Eckert, L. Johansson, W. Russell, K. Riesbeck, O. Soehnlein, L. Lindbom, A. Norrby-Teglund, R. R. Schumann, L. Bj\u00f6rck, H. Herwald, Streptococcal M protein: A multipotent and powerful inducer of inflammation. J. Immunol. 177, 1221\u20131228 (2006).","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.172.1.359","article-title":"Superantigenicity of streptococcal M protein","volume":"172","author":"Tomai M.","year":"1990","unstructured":"M. Tomai, M. Kotb, G. Majumdar, E. H. Beachey, Superantigenicity of streptococcal M protein. J. Exp. Med. 172, 359\u2013362 (1990).","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3201\/eid0910.030042","article-title":"Superantigens and streptococcal toxic shock syndrome","volume":"9","author":"Proft T.","year":"2003","unstructured":"T. Proft, S. Sriskandan, L. Yang, J. D. Fraser, Superantigens and streptococcal toxic shock syndrome. Emerg. Infect. Dis. 9, 1211\u20131218 (2003).","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JCM.43.4.1789-1796.2005","article-title":"Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: Results from a nationwide study","volume":"43","author":"Ekelund K.","year":"2005","unstructured":"K. Ekelund, P. Skinh\u00f8j, J. Madsen, H. B. Konradsen, Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: Results from a nationwide study. J. Clin. Microbiol. 43, 1789\u20131796 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/322018","article-title":"Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice","volume":"184","author":"Sriskandan S.","year":"2001","unstructured":"S. Sriskandan, M. Unnikrishnan, T. Krausz, H. Dewchand, S. Van Noorden, J. Cohen, D. M. Altmann, Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J. Infect. Dis. 184, 166\u2013173 (2001).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: A comparative observational study","volume":"59","author":"Linn\u00e9r A.","year":"2014","unstructured":"A. Linn\u00e9r, J. Darenberg, J. Sj\u00f6lin, B. Henriques-Normark, A. Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: A comparative observational study. Clin. Infect. Dis. 59, 851\u2013857 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: Bacterial clearance and modulation of inflammation","volume":"58","author":"Sriskandan S.","year":"2006","unstructured":"S. Sriskandan, M. Ferguson, V. Elliot, L. Faulkner, J. Cohen, Human intravenous immunoglobulin for experimental streptococcal toxic shock: Bacterial clearance and modulation of inflammation. J. Antimicrob. Chemother. 58, 117\u2013124 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles S.","year":"2005","unstructured":"S. Jolles, W. A. C. Sewell, S. A. Misbah, Clinical uses of intravenous immunoglobulin. Clin. Exp. Immunol. 142, 1\u201311 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1462-5822.2005.00618.x","article-title":"Integrin-linked kinase is an essential link between integrins and uptake of bacterial pathogens by epithelial cells","volume":"8","author":"Wang B.","year":"2006","unstructured":"B. Wang, R. S. Yurecko, S. Dedhar, P. P. Cleary, Integrin-linked kinase is an essential link between integrins and uptake of bacterial pathogens by epithelial cells. Cell. Microbiol. 8, 257\u2013266 (2006).","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.168.6.3050","article-title":"A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice","volume":"168","author":"Chen Z.","year":"2002","unstructured":"Z. Chen, N. Dudek, O. Wijburg, R. Strugnell, L. Brown, G. Deliyannis, D. Jackson, F. Koentgen, T. Gordon, J. McCluskey, A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. J. Immunol. 168, 3050\u20133056 (2002).","journal-title":"J. Immunol."},{"key":"e_1_3_2_44_2","unstructured":"Centers for Disease Control and Prevention Protocol for emm typing; www.cdc.gov\/streplab\/groupa-strep\/emm-typing-protocol.html."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00322445","article-title":"Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes","volume":"212","author":"Goshorn S. C.","year":"1988","unstructured":"S. C. Goshorn, G. A. Bohach, P. M. Schlievert, Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes. Mol. Gen. Genet. 212, 66\u201370 (1988).","journal-title":"Mol. Gen. Genet."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1074\/jbc.M508758200","article-title":"Divergence in the plasminogen-binding group a streptococcal M protein family: Functional conservation of binding site and potential role for immune selection of variants","volume":"281","author":"Sanderson-Smith M.","year":"2006","unstructured":"M. Sanderson-Smith, M. Batzloff, K. S. Sriprakash, M. Dowton, M. Ranson, M. J. Walker, Divergence in the plasminogen-binding group a streptococcal M protein family: Functional conservation of binding site and potential role for immune selection of variants. J. Biol. Chem. 281, 3217\u20133226 (2006).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2334-14-294","article-title":"Distribution of superantigens in group A streptococcal isolates from Salvador, Brazil","volume":"14","author":"Berman H. F.","year":"2014","unstructured":"H. F. Berman, S. Y. Tartof, J. N. Reis, M. G. Reis, L. W. Riley, Distribution of superantigens in group A streptococcal isolates from Salvador, Brazil. BMC Infect. Dis. 14, 294 (2014).","journal-title":"BMC Infect. Dis."}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aax3013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:40:04Z","timestamp":1704800404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aax3013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,6]]}},"alternative-id":["10.1126\/sciadv.aax3013"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aax3013","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"article-number":"eaax3013"}}